Cenra Inc. (TPE:3716)

Taiwan · Delayed Price · Currency is TWD

32.90

-0.25 (-0.75%)

At close: Nov 6, 2026

Market Cap	4.79B -3.0%
Revenue (ttm)	8.44B -3.9%
Net Income	510.27M +72.0%
EPS	4.07 +60.2%
Shares Out	145.69M
PE Ratio	8.08
Forward PE	n/a
Dividend	1.00 (3.05%)
Ex-Dividend Date	Jul 23, 2026

Volume	252,143
Open	32.80
Previous Close	33.15
Day's Range	32.25 - 33.00
52-Week Range	31.55 - 37.65
Beta	0.23
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 11, 2026

About Cenra

Cenra Inc. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. It provides CDMO services for internal and external partners; oral solids, injectables, specialty formulations, and APIs, supported by process development, scale-up, and regulatory support; oral solids, injectables, specialty formulations, and high-purity active pharmaceutical ingredients (APIs), supported by process development, scale-up, and regulatory support; distribution, and marketing for pres... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 2024

Employees 542

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 3716

Full Company Profile

Financial Performance

In 2025, Cenra's revenue was 8.57 billion, a decrease of -3.91% compared to the previous year's 8.92 billion. Earnings were 300.07 million, a decrease of -5.44%.

Financial Statements